TMJ Dysfunction and Motor Severity in Children With CP
TEMPOROMANDIBULAR JOINT DYSFUNCTION IN CHILDREN WITH CEREBRAL PALSY: ASSOCIATIONS WITH GMFCS LEVELS, SUBTYPES, AND BRUXISM
2 other identifiers
observational
517
1 country
1
Brief Summary
This study aims to examine the function of the temporomandibular joint (TMJ)-the jaw joint-in children with cerebral palsy (CP). Children with CP often experience difficulties in jaw movement, pain, or involuntary grinding of teeth (bruxism), which can affect their ability to eat, speak, or smile comfortably. The research will investigate how the severity of motor impairment, as classified by the Gross Motor Function Classification System (GMFCS), and different CP subtypes are related to jaw function problems. The study also explores the relationship between bruxism and TMJ pain and dysfunction. By performing clinical evaluations of mouth opening, jaw movements, muscle tenderness, and pain levels, this study hopes to identify early signs of TMJ problems. The goal is to provide better recommendations for early screening, therapy, and rehabilitation for children with CP, especially those with more severe motor impairments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2024
CompletedFirst Submitted
Initial submission to the registry
June 21, 2025
CompletedFirst Posted
Study publicly available on registry
June 29, 2025
CompletedJune 29, 2025
June 1, 2025
6 months
June 21, 2025
June 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Temporomandibular Joint (TMJ) Functional Status
Evaluation of TMJ functions using maximum mouth opening (mm), lateral jaw movement (mm), presence of joint sounds (click/crepitus), palpation tenderness, and Visual Analog Scale (VAS) for pain.
Single assessment at baseline
Secondary Outcomes (3)
Bruxism Prevalence
Single assessment at baseline
Gross Motor Function Level (GMFCS)
Single assessment at baseline
CP Subtype Distribution
Single assessment at baseline
Study Arms (1)
Cerebral palsy
GMFCS Level 1-4
Interventions
TMJ functions were assessed using the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD).
Eligibility Criteria
The study population consists of children and adolescents aged 6 to 18 years who have been clinically diagnosed with cerebral palsy (CP) and classified within Gross Motor Function Classification System (GMFCS) Levels I to IV. Participants will be recruited from pediatric neurology and physical therapy outpatient clinics of tertiary hospitals. The population is expected to represent a diverse range of CP subtypes (spastic, dyskinetic/ataxic, and mixed) and levels of functional motor impairment, allowing for subgroup analysis in relation to temporomandibular joint (TMJ) function. Participants must be able to comply with basic oral-motor assessments and have obtained informed consent from their parent(s) or legal guardian(s).
You may qualify if:
- Diagnosed with cerebral palsy (CP) by a pediatric neurologist, based on standard clinical criteria.
- Aged between 6 and 18 years.
- Classified as GMFCS Levels I to IV.
- Able to comply with clinical assessment procedures.
You may not qualify if:
- GMFCS Level V (due to inability to cooperate with TMJ examination).
- History of craniofacial trauma, surgery, or congenital maxillofacial anomalies.
- Presence of neuromuscular diseases other than cerebral palsy.
- Active temporomandibular joint infection or acute systemic illness at the time of evaluation.
- Ongoing use of muscle relaxants or botulinum toxin injections in the jaw region within the past 6 months.
- Inability to complete the TMJ clinical examination due to behavioral or cognitive limitations.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Istanbul Arel Universitylead
- Kayseri Universitycollaborator
Study Sites (1)
Kayseri University
Kayseri, Kayseri, 38130, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asst. Prof.
Study Record Dates
First Submitted
June 21, 2025
First Posted
June 29, 2025
Study Start
July 30, 2023
Primary Completion
January 30, 2024
Study Completion
July 30, 2024
Last Updated
June 29, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share